Glickman, Michael S.
Memorial Sloan Kettering Cancer Center · Cornell University · Weill Cornell Medicine
4 papers on CoChatORCID 0000-0001-7918-5164
Most cited papers
- Verified
TOX is a critical regulator of tumour-specific T cell differentiation
Scott, A. C., Dündar, F., Zumbo, P., Chandran, S. S., Klebanoff, C. A., Shakiba, M., Trivedi, P., Menocal, L., Appleby, H., Camara, S., et al. (2019) · Nature
T-cell and B-cell ImmunologyCancer Immunotherapy and Biomarkers
Cited by 1,106
- Verified
The mechanism of action of BCG therapy for bladder cancer--a current perspective
Redelman-Sidi, G., Glickman, M. S., & Bochner, B. H. (2014) · Nature Reviews Urology
Bladder and Urothelial Cancer TreatmentsUrinary Bladder and Prostate Research
Cited by 729
- Verified
Mycobacterium tuberculosis controls host innate immune activation through cyclopropane modification of a glycolipid effector molecule
Rao, V., Fujiwara, N., Porcelli, S. A., & Glickman, M. S. (2005) · The Journal of Experimental Medicine
Tuberculosis Research and EpidemiologyImmune responses and vaccinations
Cited by 238
- Verified
Two Accessory Proteins Govern MmpL3 Mycolic Acid Transport in Mycobacteria
Fay, A., Czudnochowski, N., Rock, J. M., Johnson, J. R., Krogan, N. J., Rosenberg, O., & Glickman, M. S. (2019) · mBio
Tuberculosis Research and EpidemiologyBacterial Genetics and Biotechnology
Cited by 65
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free